Sample Briefing
This is what lands in your inbox.
A Product Intelligence Briefing — showing what a subscriber monitoring 3 products would receive. Every FDA action reviewed, matched against their specific ingredients, with analysis and action items already written.
Illustrative sample. Company names and specific details are fictional. Real briefings are personalized to your products.
Product Intelligence Briefing — March 7, 2026
2 of your 3 products are affected this week.
A warning letter targeting marine collagen identity testing and a proposed BHA ban both affect products in your portfolio. Action items and deadlines below.
YOUR PRODUCTS
Marine Collagen Powder
Coastal Nutrition Co. received a warning letter for identity-testing failures on marine-sourced collagen. The FDA cited that COA-only documentation was insufficient — ingredient-specific identity tests are required. Your product contains marine collagen as a primary ingredient and is directly affected by this enforcement precedent.
ITEMS TO CONSIDER
1. Audit your identity testing protocols for marine collagen against 21 CFR 111.75(a)(1)(ii)
2. Verify COA documentation includes marine collagen-specific identity tests, not just generic protein analysis
3. Confirm with your contract manufacturer that identity tests are performed per batch, not per lot
Deadline: June 30, 2026
21 CFR 111.75(a)(1)(ii) View source document →
AI-generated analysis. Verify with source documents.
Daily Greens Superfood Blend
FDA proposed revoking the GRAS status of butylated hydroxyanisole (BHA) in food products. Your Daily Greens blend lists BHA as a preservative. If finalized, products containing BHA must reformulate or be removed from market. Comment period open.
ITEMS TO CONSIDER
1. Evaluate alternative preservative systems for your blend (tocopherols, rosemary extract)
2. Submit public comment if this rule would impact your business — comment period closes May 15, 2026
3. Begin reformulation planning — if finalized, compliance deadline is expected 18-24 months from final rule
Deadline: May 15, 2026 (comment period)
21 CFR 172.110 View source document →
AI-generated analysis. Verify with source documents.
YOUR INDUSTRY
FDA Announces Increased CGMP Inspection Frequency for Dietary Supplements
CFSAN announced a 40% increase in supplement manufacturing inspections for FY2026, focusing on identity testing and contamination controls...
MoCRA Biennial Registration Renewal Deadline Approaching — July 2026
Cosmetic facility registrations must be renewed by July 1, 2026. FDA has begun sending reminder notices to registered facilities...
ACROSS FDA THIS WEEK
FDA approves new food contact substance notification for recycled PET packaging Source →
CDER issues draft guidance on biosimilar product labeling requirements Source →
CTP proposes restrictions on characterizing flavors in tobacco products Source →
CDRH recalls Class II infusion pump over software dosing error Source →
Policy Canary | Product Intelligence Briefing AI-generated from public FDA sources. Regulatory intelligence for your review, not legal advice. Verify with source documents and qualified professionals. Policy Canary is not a law firm.
Manage your products · LinkedIn
Policy Canary, 9901 Brodie Lane Ste 160 #1323, Austin, TX 78748
Header
Timestamped and versioned
Every briefing is dated. Your compliance records need audit trails — this is one.
What each section means
Header
Timestamped and versioned
Every briefing is dated. Your compliance records need audit trails — this is one.
Bottom Line
5-second triage
How many of your products are affected and what matters most. You know immediately whether to keep reading or forward to your team.
This subscriber monitors 3 products. One had an all-clear this week — the silence is part of the value.
Your Products
Product-level intelligence
Not 'supplement industry news.' YOUR Marine Collagen Powder, matched by ingredient against FDA enforcement activity. The product name is the headline.
Action Items
What to do, by when
Numbered steps with a specific deadline and the CFR citation. Not 'consult your lawyer' — concrete actions you can take this week.
Warning letter remediation can cost $25K–$100K+. These three steps cost an afternoon.
Your Products
Calibrated urgency
'Urgent' means act now — a confirmed enforcement action. 'Watch' means a proposed rule still in comment period. Not everything is treated like a crisis.
Your Industry
Sector context, not noise
Items in your regulatory space that don't directly hit your products — but you should know about. Inspection trends, registration deadlines, enforcement patterns.
Across FDA
The full landscape in one glance
Devices, pharma, tobacco — anything outside your sector, summarized. If something here starts affecting your products, it moves up automatically.
The alternative
FDA Updates Identity Testing Requirements for Marine-Sourced Supplements — Oct 14, 2025
FDA Proposes Revoking GRAS Status of BHA in Food Products — Feb 28, 2026
No product match. No action items. No deadlines. No analysis. Just headlines.
Same two regulatory actions. The difference is the mapping — which of your products are affected, what to do, and by when.
Add your products. Get this in your inbox.
We review every FDA action against your specific ingredients and deliver the analysis \u2014 so you don't have to. Start your free trial.
Start Free Trial